Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michal Dadlez
Limited Predictive Value of Achieving Beneficial Plasma (Z)-Endoxifen Threshold Level by CYP2D6 Genotyping in Tamoxifen-Treated Polish Women With Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Pre-Analytical-Related Variability Influencing Serum Peptide Profiles Demonstrated in a Mass Spectrometry-Based Search for Colorectal and Prostate Cancer Biomarkers.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Related publications
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen
Frontiers in Pharmacology
Pharmacology
Pcn191 - Cost-Effectiveness of Monitoring Endoxifen Levels in Breast Cancer Patients Adjuvantly Treated With Tamoxifen
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
CYP2D6 Genotyping and Tamoxifen in the Treatment of Post-Menopausal Breast Cancer - A Reply
British Journal of Clinical Pharmacology
Pharmacology
Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy
Breast Cancer Research and Treatment
Cancer Research
Oncology
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
Pharmaceuticals
Molecular Medicine
Pharmaceutical Science
Pharmacogenetics and Breast Cancer Endocrine Therapy: CYP2D6 as a Predictive Factor for Tamoxifen Metabolism and Drug Response?
Expert Reviews in Molecular Medicine
Molecular Medicine
Molecular Biology
Tamoxifen Alters the Plasma Concentration of Molecules Associated With Cardiovascular Risk in Women With Breast Cancer Undergoing Chemotherapy
Oncologist
Cancer Research
Medicine
Oncology
Pap Smear Results of Women With Breast Cancer Using Tamoxifen Therapy
Istanbul Medical Journal
Ovarian Cysts in Women Receiving Tamoxifen for Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
